News
Open Access
- 15 June 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (12)
- https://doi.org/10.1086/512288
Abstract
27 April—(icanNEWS) A US Food and Drug Administration (FDA) committee yesterday gave a mixed endorsement to telithromycin, the first of the ketolide family of antibiotics, recommending its approval as a first-line treatment for community-acquired pneumonia (CAP) but not accepting claims that it is a new weapon for treating penicillin- and erythromycin-resistant pneumonia.Keywords
This publication has 0 references indexed in Scilit: